featured
Risk of Dupilumab Use for Atopic Dermatitis During the COVID-19 Pandemic
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessing the Risk of Dupilumab Use for Atopic Dermatitis During the COVID-19 Pandemic
J Am Acad Dermatol 2020 Jun 10;[EPub Ahead of Print], DG Kearns, S Uppal, VS Chat, JJ WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.